Insider Trading History of Oyler John

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Oyler John since 2017. This trader's CIK number is 1042047. At the time of last reporting, Oyler John was the Chief Executive Officer of Beone Medicines Ltd.. (stock ticker symbol ONC). Also see all insider trading activities at Beone Medicines Ltd..



Yearly summary of insider trading at Beone Medicines Ltd. (ONC) by Oyler John

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 ONC 0 $0 181,152 $45,660,427 1,832,639 $6,414,236
2024 ONC 0 $0 120,245 $20,348,624 1,300,000 $650,000
2023 ONC 0 $0 20,391 $5,071,567 0 $0
2022 ONC 0 $0 89,537 $15,984,367 0 $0
2021 ONC 0 $0 1,240,518 $374,284,425 0 $0
2020 ONC 0 $0 576,886 $134,376,588 0 $0
2019 ONC 0 $0 93,688 $14,707,597 0 $0
2018 ONC 0 $0 134,883 $19,528,131 0 $0
2017 ONC 0 $0 961,000 $63,394,296 0 $0


Insider trading of Beone Medicines Ltd. (ONC) by Oyler John

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-07-09 ONC Sale 27,802 253.59 7,050,225
2025-06-23 ONC Sale 3,174 262.24 832,337
2025-06-16 ONC Sale 3,680 266.05 979,045
2025-06-17 ONC Sale 1,460 256.49 374,473
2025-06-06 ONC Sale 5,127 253.38 1,299,094
2025-03-10 BGNE Sale 41,210 242.91 10,010,238
2025-03-10 BGNE Option Ex 539,032 3.50 1,886,612
2025-03-06 BGNE Sale 40,109 260.48 10,447,712
2025-03-06 BGNE Option Ex 526,270 3.50 1,841,945
2025-03-07 BGNE Sale 58,590 250.34 14,667,303
2025-03-07 BGNE Option Ex 767,337 3.50 2,685,679
2024-12-14 BGNE Option Ex 1,300,000 .50 650,000
2024-10-08 BGNE Sale 16,175 232.77 3,765,070
2024-06-24 BGNE Sale 2,789 159.81 445,701
2024-06-17 BGNE Sale 1,281 159.28 204,037
2024-04-09 BGNE Sale 11,200 153.32 1,717,195
2024-04-10 BGNE Sale 26,716 149.55 3,995,324
2024-04-11 BGNE Sale 12,084 146.88 1,774,922
2024-03-12 BGNE Sale 37,668 165.33 6,227,688
2024-03-13 BGNE Sale 12,332 179.91 2,218,687
2023-01-10 BGNE Sale 20,391 248.72 5,071,567
2022-12-29 BGNE Sale 5,150 224.78 1,157,596
2022-12-28 BGNE Sale 1,100 224.72 247,197
2022-12-27 BGNE Sale 3,359 224.29 753,403
2022-11-15 BGNE Sale 29,928 206.85 6,190,726
2022-09-20 BGNE Sale 30,520 153.97 4,699,011
2022-09-21 BGNE Sale 19,480 150.74 2,936,434
2021-09-15 BGNE Sale 216,361 339.76 73,510,596
2021-09-14 BGNE Sale 195,477 332.51 64,999,034
2021-09-01 BGNE Sale 153,059 225.50 34,514,345
2021-09-02 BGNE Sale 24,499 328.65 8,051,669
2021-08-31 BGNE Sale 111,081 275.69 30,623,809
2021-08-04 BGNE Sale 80,847 309.36 25,010,666
2021-08-05 BGNE Sale 44,462 317.25 14,105,702
2021-08-03 BGNE Sale 83,359 318.02 26,509,912
2021-07-22 BGNE Sale 69,216 293.13 20,289,147
2021-07-21 BGNE Sale 27,160 280.66 7,622,671
2021-07-20 BGNE Sale 43,695 277.41 12,121,255
2021-07-06 BGNE Sale 57,375 296.19 16,994,130
2021-07-07 BGNE Sale 66,446 297.49 19,766,754
2021-07-07 BGNE Sale 300 325.23 97,569
2021-07-08 BGNE Sale 67,181 298.70 20,067,166
2020-09-29 BGNE Sale 23,303 278.75 6,495,618
2020-09-28 BGNE Sale 31,000 280.38 8,691,873
2020-09-14 BGNE Sale 19,739 250.05 4,935,717
2020-09-15 BGNE Sale 34,214 254.78 8,716,974
2020-09-16 BGNE Sale 27,275 255.91 6,979,999
2020-08-31 BGNE Sale 12,961 240.53 3,117,457
2020-09-02 BGNE Sale 27,807 229.83 6,390,994
2020-09-01 BGNE Sale 20,274 235.15 4,767,512
2020-08-19 BGNE Sale 29,866 234.76 7,011,222
2020-08-20 BGNE Sale 21,523 233.80 5,032,012
2020-08-21 BGNE Sale 40,788 240.72 9,818,364
2020-08-12 BGNE Sale 19,820 211.82 4,198,272
2020-08-13 BGNE Sale 14,443 213.72 3,086,815
2020-08-14 BGNE Sale 8,705 211.82 1,843,866
2020-08-05 BGNE Sale 17,254 223.20 3,851,041
2020-08-03 BGNE Sale 25,176 220.02 5,539,248
2020-08-04 BGNE Sale 15,383 221.28 3,403,904
2020-07-21 BGNE Sale 26,413 251.88 6,652,906
2020-07-20 BGNE Sale 28,762 251.56 7,235,282
2020-07-22 BGNE Sale 27,748 241.54 6,702,307
2020-07-06 BGNE Sale 17,362 196.95 3,419,480
2020-07-07 BGNE Sale 19,023 198.38 3,773,725
2020-07-08 BGNE Sale 17,529 200.30 3,510,988
2020-07-01 BGNE Sale 3,816 191.59 731,122
2020-06-29 BGNE Sale 1,435 192.69 276,515
2020-06-24 BGNE Sale 14,381 187.71 2,699,399
2020-06-22 BGNE Sale 10,281 181.68 1,867,800
2020-06-23 BGNE Sale 15,070 186.52 2,810,916
2020-06-10 BGNE Sale 900 175.07 157,563
2020-05-01 BGNE Sale 4,635 141.90 657,697
2019-12-17 BGNE Sale 62,259 161.65 10,063,980
2019-07-08 BGNE Sale 3,106 127.37 395,605
2019-05-01 BGNE Sale 2,824 125.62 354,748
2019-03-06 BGNE Sale 100 150.00 15,000
2019-03-05 BGNE Sale 11,021 152.73 1,683,204
2019-03-04 BGNE Sale 14,378 152.67 2,195,060
2018-12-10 BGNE Sale 4,138 135.66 561,356
2018-11-26 BGNE Sale 9,078 138.81 1,260,162
2018-11-27 BGNE Sale 11,252 143.30 1,612,434
2018-11-28 BGNE Sale 8,865 146.77 1,301,107
2018-07-16 BGNE Sale 2,550 164.12 418,498
2018-03-01 BGNE Sale 39,300 142.21 5,588,695
2018-03-02 BGNE Sale 25,362 146.20 3,707,873
2018-02-28 BGNE Sale 34,338 147.88 5,078,006
2017-12-26 BGNE Sale 20,137 97.84 1,970,163
2017-12-08 BGNE Sale 52,817 95.73 5,056,329
2017-12-06 BGNE Sale 31,446 92.70 2,915,169
2017-12-07 BGNE Sale 59,737 94.50 5,645,086
2017-11-28 BGNE Sale 32,985 85.52 2,820,877
2017-11-27 BGNE Sale 16,581 87.12 1,444,536
2017-11-29 BGNE Sale 36,340 82.92 3,013,458
2017-11-13 BGNE Sale 25,054 83.32 2,087,399
2017-11-14 BGNE Sale 59,835 80.21 4,799,544
2017-11-15 BGNE Sale 66,068 80.10 5,291,782
2017-07-06 BGNE Sale 219,400 64.45 14,140,768
2017-06-22 BGNE Sale 58,605 44.42 2,603,234
2017-06-23 BGNE Sale 39,895 44.73 1,784,662
2017-04-27 BGNE Sale 34,049 40.37 1,374,558
2017-05-01 BGNE Sale 2,100 42.02 88,244
2017-03-20 BGNE Sale 13,234 40.02 529,611
2017-03-17 BGNE Sale 2,717 40.02 108,737
2017-03-16 BGNE Sale 16,038 39.06 626,508
2017-03-06 BGNE Sale 19,816 40.43 801,220
2017-03-02 BGNE Sale 49,092 41.25 2,025,094
2017-03-03 BGNE Sale 40,091 40.90 1,639,721
2017-02-21 BGNE Sale 10,359 40.09 415,344
2017-02-16 BGNE Sale 47,400 40.49 1,919,273
2017-02-17 BGNE Sale 7,204 40.67 292,979

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Oyler John (Chief Executive Officer of Beone Medicines Ltd. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.